Values are regression coefficients (error bars indicate 95% confidence intervals) and represent the change (standard deviation score) of head circumference, femur length, and estimated fetal weight per increase of 1 standard deviation in first-trimester fetal crown to rump length. All models are adjusted for fetal sex. Head circumference was not available at 24 months of age.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Mook-Kanamori DO, Steegers EAP, Eilers PH, Raat H, Hofman A, Jaddoe VWV. Risk Factors and Outcomes Associated With First-Trimester Fetal Growth Restriction. JAMA. 2010;303(6):527–534. doi:10.1001/jama.2010.78
Author Affiliations: The Generation R Study Group (Drs Mook-Kanamori and Jaddoe); Departments of Epidemiology (Drs Mook-Kanamori, Hofman, and Jaddoe), Pediatrics (Drs Mook-Kanamori and Jaddoe), Obstetrics & Gynecology (Dr Steegers), Biostatistics (Dr Eilers), and Public Health (Dr Raat), Erasmus Medical Center, Rotterdam, the Netherlands.
Context Adverse environmental exposures lead to developmental adaptations in fetal life. The influences of maternal physical characteristics and lifestyle habits on first-trimester fetal adaptations and the postnatal consequences are not known.
Objective To determine the risk factors and outcomes associated with first-trimester growth restriction.
Design, Setting, and Participants Prospective evaluation of the associations of maternal physical characteristics and lifestyle habits with first-trimester fetal crown to rump length in 1631 mothers with a known and reliable first day of their last menstrual period and a regular menstrual cycle. Subsequently, we assessed the associations of first-trimester fetal growth restriction with the risks of adverse birth outcomes and postnatal growth acceleration until the age of 2 years. The study was based in Rotterdam, the Netherlands. Mothers were enrolled between 2001 and 2005.
Main Outcome Measures First-trimester fetal growth was measured as fetal crown to rump length by ultrasound between the gestational age of 10 weeks 0 days and 13 weeks 6 days. Main birth outcomes were preterm birth (gestational age <37 weeks), low birth weight (<2500 g), and small size for gestational age (lowest fifth birth centile). Postnatal growth was measured until the age of 2 years.
Results In the multivariate analysis, maternal age was positively associated with first-trimester fetal crown to rump length (difference per maternal year of age, 0.79 mm; 95% confidence interval [CI], 0.41 to 1.18 per standard deviation score increase). Higher diastolic blood pressure and higher hematocrit levels were associated with a shorter crown to rump length (differences, −0.40 mm; 95% CI, −0.74 to −0.06 and −0.52 mm; 95% CI, −0.90 to −0.14 per standard deviation increase, respectively). Compared with mothers who were nonsmokers and optimal users of folic acid supplements, those who both smoked and did not use folic acid supplements had shorter fetal crown to rump lengths (difference, −3.84 mm; 95% CI, −5.71 to −1.98). Compared with normal first-trimester fetal growth, first-trimester growth restriction was associated with increased risks of preterm birth (4.0% vs 7.2%; adjusted odds ratio [OR], 2.12; 95% CI, 1.24 to 3.61), low birth weight (3.5% vs 7.5%; adjusted OR, 2.42; 95% CI, 1.41 to 4.16), and small size for gestational age at birth (4.0% vs 10.6%; adjusted OR, 2.64; 95% CI, 1.64 to 4.25). Each standard deviation decrease in first-trimester fetal crown to rump length was associated with a postnatal growth acceleration until the age of 2 years (standard deviation score increase, 0.139 per 2 years; 95% CI, 0.097 to 0.181).
Conclusions Maternal physical characteristics and lifestyle habits were independently associated with early fetal growth. First-trimester fetal growth restriction was associated with an increased risk of adverse birth outcomes and growth acceleration in early childhood.
Fetal developmental adaptations due to adverse environmental exposures may affect the structure, physiology, and function of various organ systems leading to fetal growth restriction and increased risks of metabolic and cardiovascular disease in adulthood.1,2 Human growth and development rates are highest during the first trimester of pregnancy, when essential fetal organ development is completed.3 Adverse first-trimester fetal exposures might have permanent consequences for fetal and postnatal health.
First-trimester fetal crown to rump length is used in obstetric care practice for pregnancy dating, assuming no growth variation.4 Studies among women with a regular menstrual cycle suggest that maternal age, ethnicity, and fetal sex are associated with fetal crown to rump length.5,6 Maternal smoking, alcohol consumption, and folic acid supplement use influence birth weight,7,8 but their associations with first-trimester fetal growth are not known. Two studies suggested that first-trimester fetal growth restriction increases the risks of low birth weight and small size for gestational age.9,10 The relationship between first-trimester fetal growth restriction and postnatal health outcomes remains unknown.
In a population-based prospective cohort study among mothers with a known first day of the last menstrual period, we examined the associations of several maternal physical characteristics and lifestyle habits with first-trimester fetal growth. Subsequently, we examined whether first-trimester fetal growth restriction is associated with the risks of adverse birth outcomes and growth adaptations during fetal life and early childhood.
This study was embedded in the Generation R Study, a population-based prospective cohort study from early fetal life onward in Rotterdam, the Netherlands.11 The study has been approved by the medical ethics committee of the Erasmus Medical Center, Rotterdam, the Netherlands. Written informed consent for both maternal and child data was obtained from all mothers.
Mothers enrolled between 2001 and 2005. Fetal crown to rump length was measured in 4195 mothers with singleton pregnancies (Figure 1). Of these mothers, 3083 had measurements within the recommended gestational age range of 10 weeks 0 days and 13 weeks 6 days.12 Mothers who did not undergo prenatal examinations within this time frame (n = 1112) and those in whom pregnancy ended with miscarriage or stillbirth (n = 21) were excluded, since gestational age at time of death with subsequent arrest of fetal growth could not be ascertained.13 Mothers with neither a known first day of the last menstrual period nor a regular menstrual cycle of 28 plus or minus 4 days were excluded (n = 1431), leaving 1631 participants for the analyses. First day of the last menstrual period was obtained from the referring letter from the community midwife or hospital. This date was confirmed with the mother at the ultrasound visit and additional information on the regularity and cycle duration was obtained.
The prevalence of preeclampsia and (gestational) diabetes was 1.7% and 1.1%, respectively. Since exclusion of these women did not materially change our results, they were included in the analyses.
Information on maternal age, educational level, smoking habits, alcohol use, folic acid supplement use, parity, and mode of conception were obtained through self-administered questionnaire at enrollment (response rate 93%). Since fetal growth is known to vary between ethnicities,14 participating mothers were requested to give details regarding the country of birth of their parents. This information was used to classify participants' ethnic background according to Statistics Netherlands, as previously described in detail.14 Weight and height were measured without shoes or heavy clothing and body mass index was calculated (weight in kilograms divided by height in meters squared). Blood pressure was measured with the validated Omron 907 automated digital oscillometric sphygmomanometer (OMRON Healthcare Europe B.V. Hoofddorp, the Netherlands). After being seated in an upright position for at least 5 minutes, the mean value of 2 blood pressure readings over a 60-second interval was documented. Hematocrit and hemoglobin levels were available from first-trimester blood samples (success rate 84%).
In our research facility, we measured first-trimester (<14 weeks) crown to rump length in a true midsagittal plane with the genital tubercle and the fetal spine longitudinally in view.15 The maximum length from cranium to the caudal rump was measured as a straight line. Transvaginal scanning was performed in the case of limited visibility by transabdominal scanning. In the second trimester (median weeks, 20.3; 90% range, 19.1-22.0), and third (median weeks, 30.1; 90% range, 29.0-32.0), we measured fetal head circumference, biparietal diameter, abdominal circumference, and femur length to the nearest millimeter using standardized ultrasound procedures.16 Estimated fetal weight was calculated using the formula by Hadlock et al.17 Ultrasound examinations were performed using an Aloka model SSD-1700 (Tokyo, Japan) or the ATL-Philips Model HDI 5000 (Seattle, Washington).
Standard deviation scores for all fetal growth characteristics were constructed.16 Intraclass correlation coefficients for intraobserver and interobserver reproducibility of crown to rump length measurements were 0.998 and 0.995, respectively.18
Date of birth, birth anthropometrics (weight, length, head circumference) and offspring sex were obtained from community midwife and hospital registries. Gestational age and sex-adjusted standard deviation scores for birth weight, length, and head circumference were constructed using growth standards from Usher and McLean.19 Small size for gestational age at birth was defined within our study population (lowest fifth birth centile), preterm birth as a gestational age at birth of less than 37 weeks, and low birth weight as a birth weight of less than 2500 g.
Well-trained staff in community health centers obtained postnatal growth characteristics (weight, length, and head circumference) using standardized procedures.11 Based on the routine health care program, periodic visits were scheduled for 8 age periods (1, 2, 3, 4, 6, 11, 14, and 24 months). Actual median (90% range) ages (by weeks) were: 4.7 (3.6-6.6); 9.7 (8.7-12.6); 14.4 (13.0-16.9); 19.0 (17.4-21.2); 26.7 (23.7-31.0); 47.6 (43.5-53.0); 61.8 (59.3-68.2); and 107.1 (102.1-118.2). For postnatal growth characteristics, we obtained standard deviation scores using Dutch reference growth curves (Growth Analyzer 3.0, Dutch Growth Research Foundation, Rotterdam, the Netherlands).
First, we performed a nonresponse analysis by comparing characteristics of mothers who were included in the analyses to those who were excluded due to an unknown or unreliable first day of last menstrual period or an irregular menstrual cycle using the t, Mann-Whitney U, and χ2 tests. Also, we compared birth characteristics of children included in the postnatal analyses to those who were not.
Second, we created gestational age–adjusted standard deviation scores for each individual fetal measurement in our study (eAppendix). We used fetal sex and gestational age–adjusted linear regression models to assess the associations of each determinant with first-trimester fetal crown to rump length separately. To enable comparison of the effect estimates between risk factors, we present our results as change per standard deviation score for continuous variables. Subsequently, all factors associated with crown to rump length were included in 1 multivariate linear regression model. We also examined interactions between lifestyle exposures (smoking, alcohol use, and folic acid supplement use). Since the timing of ovulation is dependent of the duration of the menstrual cycle, these models were adjusted for the duration of the last menstrual cycle.
Third, we examined the associations of first-trimester fetal growth restriction, defined as gestational age–adjusted crown to rump length in the lowest 20% of the population, with the risk of adverse birth outcomes (preterm birth, small size for gestational age, and low birth weight) using univariate logistic regression models. To account for potential confounding, these models were subsequently adjusted for factors associated with fetal crown to rump length.
Finally, we studied the associations of first-trimester fetal crown to rump length with growth characteristics in the second and third trimesters and from birth until the age of 24 months using sex-adjusted linear regression models. To assess the associations of first-trimester fetal crown to rump length with longitudinally measured growth rates in childhood, we performed unbalanced repeated measures regression analysis (eAppendix).
With a sample size of 1631 women and assuming a power of 0.80 and a significance level of .05 (2-sided), we were able to detect an effect of 0.07 standard deviations. When multiple comparisons were performed, the significance level was adjusted using the Bonferroni correction. For all analyses, missing values were imputed with the mean for continuous variables or an additional category for categorical variables. We found similar results based on imputed and complete data sets. Statistical analyses were performed using the Statistical Analysis System version 9.1.3 (SAS Statistical Software, Cary, North Carolina) and the Statistical Package of Social Sciences version 15.0 (SPSS Inc, Chicago, Illinois).
Maternal and fetal characteristics are shown in Table 1. Nonresponse analysis showed that mothers with a known first day of the last menstrual period and a reliable menstrual cycle were older, more highly educated, more often white, and more frequently users of folic acid supplements (all P < .001) (eTable 1). Of all newborns, infants, and children, 7% were excluded from postnatal follow-up studies because of relocation outside of the study area and 6% were lost to follow-up for other reasons. Postnatal follow-up data were available in the remaining 87% of all newborns, infants, and children in the study. Those who were not included in the postnatal analyses had a lower birth weight (difference, 156 g; 95% CI, 61 to 251; P < .001) and a smaller size for gestational age at birth (difference, 0.50 weeks; 95% CI, 0.18 to 0.83; P = .009) compared with those included in these analyses (eTable 2).
In the univariate analyses, higher maternal age, folic acid supplement use, and having had a previous childbirth were positively associated with fetal crown to rump length (Table 2). Higher diastolic blood pressure and hematocrit level, a secondary education only, Surinamese ethnicity, and smoking were associated with a shorter fetal crown to rump length. Maternal anthropometrics were not associated with fetal crown to rump length.
In the multivariate analyses, the associations of maternal age (0.10 standard deviation score; 95% CI, 0.05 to 0.16; P < .001) per standard deviation increase in age (1 = 4.68 years), diastolic blood pressure (−0.05 standard deviation score; 95% CI, −0.10 to −0.01; P = .03) per standard deviation increase in blood pressure (1 = 9.52 mm Hg), hematocrit level (−0.07 standard deviation score; 95% CI, −0.12 to −0.01; P = .02) per standard deviation increase in hematocrit level (1 = 2.50%), smoking (−0.13 standard deviation score; 95% CI, −0.25 to −0.01; P = .03), and folic acid supplement use (0.17 standard deviation score; 95% CI, 0.33 to 0.01; P = .03) with fetal crown to rump length remained significant (Table 3). After multiple testing adjustment (6 independent risk factors), the associations with diastolic blood pressure, smoking, and folic acid supplement use were no longer significant. We also observed a dose-response association between the number of cigarettes smoked daily by the mother and fetal crown to rump length (P = .04). A stratified analysis according to gestational age indicated no interaction between gestational age and risk factors except for maternal age, in which the effect size increased with increasing gestational age (P = .002; eTable 3).
We observed an interaction of maternal smoking and folic acid intake (P < .001), indicating that mothers who smoked and did not use folic acid supplements had a smaller fetal crown to rump length growth (−0.52 standard deviation score; 95% CI, −0.78 to −0.25; or −3.84 mm; 95% CI, −5.71 to −1.98) compared with nonsmoking mothers who used folic acid supplements (eFigure 2). We did not observe other interactions between smoking, alcohol use, and folic acid supplement use (all P > .1).
Small first-trimester fetal crown to rump length, defined as the lowest 20%, was associated with an increased risk of being born preterm (4.0% vs 7.2%), small size for gestational age (4.0% vs 10.6%), or with a low birth weight (3.5% vs 7.5%) (Table 4). Using the same data, sensitivity analyses with a cutoff of the lowest 10% instead of the lowest 20% for crown to rump length showed similar effect estimates for preterm birth (4.2% vs 8.8%; odds ratio [OR], 2.43; 95% CI, 1.28 to 4.59; P = .006), small size for gestational age at birth (4.5% vs 12.5%; OR, 2.50; 95% CI, 1.42 to 4.41; P = .001), and low birth weight (3.7% vs 9.4%; OR, 2.70; 95% CI, 1.43 to 5.09; P = .002).
First-trimester fetal crown to rump length was positively associated with second- and third-trimester head circumference, femur length, and estimated fetal weight (Figure 2). The associations of first-trimester fetal crown to rump length with biparietal diameter and abdominal circumference are shown in eTable 4. First-trimester crown to rump length was associated with postnatal weight until the age of 11 months (0.061 standard deviation score; 95% CI, 0.005 to 0.117; P = .03) and with postnatal head circumference and femur length until the age of 14 months (0.080 standard deviation score; 95% CI, 0.012 to 0.148; P = .02 and 0.065 standard deviation score; 95% CI, 0.007 to 0.122; P = .03, respectively). No associations between crown to rump length and growth parameters at the age of 2 years were found. In these children, each standard deviation decrease in first-trimester fetal crown to rump length was associated with an accelerated growth rate in weight and height during the first 2 years (increase of 0.139 standard deviation score per 2 years; 95% CI, 0.097 to 0.181; P < .001 and 0.128 standard deviation score per 2 years; 95% CI, 0.085 to 0.173; P < .001, respectively). These associations were independent of birth weight.
This study showed that maternal physical characteristics and lifestyle habits are associated with first-trimester crown to rump length as a measure of first-trimester fetal growth. Shorter first-trimester crown to rump length was associated with increased risks of preterm birth, small size for gestational age at birth, and low birth weight. Furthermore, shorter first-trimester crown to rump length was associated with accelerated growth rates in early childhood.
We used the first day of the last menstrual period to determine gestational age at crown to rump length measurement. To avoid misclassification, we included only pregnant women with a known and reliable first day of the last menstrual period and a regular menstrual cycle of approximately 28 days. Misclassification of gestational age might still be an issue since the postconceptional age at the time of ultrasound is dependent on the timing of ovulation and implantation, which we were unable to measure. For example, the duration of the follicular phase, after which ovulation occurs, has been shown to also be associated with several maternal factors such as maternal age and smoking.20 Furthermore, dating of the last menstrual period can be confounded by recall bias.21 However, all our results remained after adjustment for the duration of last menstrual cycle, which is highly associated with the timing of ovulation. Moreover, even with a known and reliable last menstrual period, a certain fraction of women with regular cycles have early or delayed ovulation. Nonetheless, restriction to participants who had a gestational age based on last menstruation within 7 days of a gestational age based on crown to rump length (93%) did not materially change our effect estimates.
Mothers with a known and reliable last menstrual period were on average older, taller, more likely to be higher educated and Dutch, consume alcohol, and use folic acid supplements than those with an unreliable menstrual cycle. Our effect estimates would be biased if the associations between risk factors and first-trimester fetal growth would differ between individuals included and not included in the analysis. This seems unlikely.22
Children lost to follow-up were on average smaller at birth, which is a risk factor for postnatal growth acceleration.23 This might have led to an underestimation of the postnatal growth rates in children with first-trimester fetal growth restriction. Restricting the analyses on birth outcomes to those children with complete fetal and postnatal data did not materially change the associations with the risks of adverse birth outcomes.
Birth weight is the end point of different fetal growth patterns and adverse exposures that may influence fetal growth as early as the first trimester. Previous studies suggested that maternal age, black race, and male sex are associated with longer first-trimester crown to rump length.5,6 We found negative associations of higher diastolic blood pressure and hematocrit with first-trimester crown to rump length. Higher blood pressure in early pregnancy is known to be associated with an increased risk of developing placenta-related problems such as preeclampsia and fetal growth restriction in later pregnancy.24 A possible explanation is that higher hematocrit levels are indicative of a lower circulating plasma volume, which subsequently might lead to a suboptimal placental perfusion.25 Finally, maternal anthropometrics were not associated with first-trimester crown to rump length, indicating that the previously found associations between maternal weight and birth weight develop in later pregnancy.26
Smoking and the nonuse of folic acid supplements were associated with shorter first-trimester growth. Folic acid serves as a substrate for various cellular processes such as cell division and apoptosis, which are implicated in fetal and placental growth and development.27 Furthermore, both smoking and folic acid seem to be involved in DNA methylation, which may subsequently affect early fetal and postnatal growth.28 There was a strong additive interaction between smoking and folic acid supplement intake. Jauniaux et al29 described that folic acid levels in serum levels and coelomic fluid were lower in smokers than nonsmokers, suggesting that smoking may lead to an impaired bioavailability of folic acid. Smoking during pregnancy also induces morphological and functional changes in the placenta, leading to a reduction of fetal-placental blood flow.30 Further studies on the effects of these lifestyle factors on early markers of abnormal placentation, such as pregnancy-associated plasma protein A and free human chorionic gonadotropin-β, will allow us to examine in greater detail what role placental function plays in the relationship between these factors and early fetal growth.31
First-trimester fetal growth restriction was associated with increased risks of prematurity, small size for gestational age at birth, and low birth weight, which are associated with increased perinatal mortality and morbidity. These findings are consistent with results from 2 previous studies, one in spontaneously conceived pregnancies and the other in pregnancies resulting from assisted reproductive technology.9,10 Shorter first-trimester crown to rump length may be an intermediate in the pathway between adverse maternal risk factors, such as smoking and nonuse of folic acid supplements, and growth variation in later pregnancy and possibly later life.32
Our results indicate that first-trimester growth variation is associated with growth parameters in early childhood. Smaller first-trimester fetal crown to rump length led to compensatory accelerated postnatal growth. Subsequently, at the age of 24 months there was no longer an association between fetal growth restriction and postnatal growth parameters. Increased postnatal growth rate is a well-established risk factor for metabolic and cardiovascular disease in later life.23,33 It could be that growth as early as in the first trimester of pregnancy is associated with disease in adulthood, although longer follow-up studies are necessary to examine this relationship.
In conclusion, our study demonstrates that first-trimester fetal growth is associated with several maternal physical characteristics and lifestyle habits. First-trimester growth restriction is associated with higher risks of adverse birth outcomes and accelerated postnatal growth rates. Further studies are needed to assess the associations of first-trimester growth variation on the risks of disease in later childhood and adulthood.
Corresponding Author: Vincent W. V. Jaddoe, MD, PhD, The Generation R Study Group (AE-006), Erasmus Medical Center, PO Box 2040, 3000 CA Rotterdam, the Netherlands (firstname.lastname@example.org).
Author Contributions: Drs Mook-Kanamori and Jaddoe had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Steegers, Raat, Hofman, Jaddoe.
Acquisition of data: Mook-Kanamori, Jaddoe.
Analysis and interpretation of data: Mook-Kanamori, Steegers, Eilers, Jaddoe.
Drafting of the manuscript: Mook-Kanamori, Steegers.
Critical revision of the manuscript for important intellectual content: Mook-Kanamori, Steegers, Eilers, Raat, Hofman, Jaddoe.
Statistical analysis: Mook-Kanamori, Eilers, Jaddoe.
Obtained funding: Steegers, Hofman, Jaddoe.
Study supervision: Steegers, Hofman, Jaddoe.
Financial Disclosures: None reported.
Funding/Support: The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the School of Law and Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, the Rotterdam Homecare Foundation, and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR), Rotterdam, the Netherlands. The first phase of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam, and the Netherlands Organization for Health Research (ZonMw 21000074). Dr Jaddoe reports receipt of funding from the Netherlands Organization for Health Research (ZonMw 90700303).
Role of the Sponsor: The funding agencies had no role in the design and conduct of the study; nor in the collection, management, analysis and interpretation of the data; nor in the preparation, review, and approval of the manuscript.
Additional Contributions: We gratefully acknowledge the contribution of general practitioners, hospitals, midwives, and pharmacies in Rotterdam.
Create a personal account or sign in to: